CD8A and neoplasm: This CCNP, in response to PTT, could induce tumor necrosis and release whole-cell tumor antigens, activate CD8+ cytotoxic T cells and reduce regulatory Foxp3+ T cells, and further enhance antitumor immunotherapy (46).